Praetego to present at the Venture Connect Summit in Raleigh NC

March 1, 2020

Praetego will showcase their candidates as potential disease modifying drugs against serious diabetic complications, starting with Diabetic Peripheral Neuropathy, at the CED NC Venture Connect Summit. The Amadorins are novel small molecules developed by Praetego scientists and designed from a clinically proven prototype.

Visit the CED NC website.